Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06388096 · ClinicalTrials.gov registry record · NA
CLAD Deconvolved PERG Responses in Glaucoma Patients
A NA study of Glaucoma, Suspect, sponsored by Jorvec.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT06388096 is a NA study of Glaucoma, Suspect that is actively recruiting participants, run by Jorvec. The registered enrollment target is 120 participants, above the 80-participant average among 3 other Glaucoma, Suspect trials with a reported enrollment target (50% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06388096, a NA study of Glaucoma, Suspect, is actively recruiting participants, sponsored by Jorvec.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
Glaucoma is a progressive disease resulting in blindness. Determining the onset of the disease is critical so patients may obtain treatment to preserve useful vision. This study will collect data from a population of glaucoma suspects (with positive factors for the disease but with normal vision) along with a population of age matched controls using the pattern electroretinogram (PERG) and other standard eye tests for glaucoma. The PERG measures the function of retinal ganglion cells (RGCs) which come together to form the optic nerve. RGCs may become dysfunctional before dying. The Continuous loop deconvolution technique (CLAD) will be used to extract transient PERG responses in both glaucoma suspects and age matched controls. All patients will be monitored with PERG, Optic Coherence Tomography (OCT) and other ancillary tests over 2 years. CLAD will be compared with conventional techniques of monitoring glaucoma (standard PERG, OCT, visual field etc) to see if the CLAD is better at distinguishing between glaucoma suspects and controls.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Pattern Electroretinogram
Study Locations (1)
Florida
- University of Miami, Bascom Palmer Eye Institute 900 NW 17th Street - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2023-06-01 |
| Est. Completion | 2025-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06388096
The ClinicalTrials.gov registry entry for NCT06388096 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 80-participant average among 3 other Glaucoma, Suspect trials with a reported enrollment target (50% higher). The listed sponsor is Jorvec, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Glaucoma, Suspect appearing as the primary indexed condition, and to 1 intervention - of which Pattern Electroretinogram is the first listed.
NCT06388096 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT06388096 about?
NCT06388096 is a clinical study titled "CLAD Deconvolved PERG Responses in Glaucoma Patients". Glaucoma is a progressive disease resulting in blindness. Determining the onset of the disease is critical so patients may obtain treatment to preserve useful vision. This study will collect data from a population of glaucoma suspects (with positive factors for the disease but with normal vision) al...
What is the current status of trial NCT06388096?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2023-06-01. Estimated completion is 2025-06-01.
What conditions does trial NCT06388096 study?
This clinical trial studies the following conditions: Glaucoma, Suspect.
What interventions are being tested in trial NCT06388096?
The interventions under investigation include: Pattern Electroretinogram (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06388096?
This trial is sponsored by Jorvec, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06388096 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glaucoma, Suspect
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.